Moneycontrol PRO

you are here: HomeNewsBusinessMarketsThere is scope for further US FDA action: JM Financial

SHOW NAMES

Trending Topics

business

There is scope for further US FDA action: JM Financial

Sun Pharma and Dr Reddy‘s are long-term winners, Anmol Ganjoo, Pharma analyst at JM Financial said adding that there is still scopr for further US FDA actions.

first published: Nov 16, 2015 04:00 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347